Velphoro

Velphoro (Sucroferric Oxyhydroxide) is an oral phosphate binder used to control high phosphate levels in adults with chronic kidney disease. This iron-based medication helps manage hyperphosphatemia by binding dietary phosphate in the digestive tract. It is suitable for patients on dialysis or with kidney disease.

Velphoro is primarily used to lower high phosphate levels in the blood for adults with chronic kidney disease, particularly those undergoing dialysis. It works by binding phosphate from food in the stomach and intestines, preventing its absorption into the bloodstream. This helps maintain healthy phosphate balance, which is important for bone and heart health in kidney disease patients.

Velphoro is designed to reduce phosphate levels in the bloodstream by binding to dietary phosphate. It is taken with meals to maximize its effect. Some users may experience mild digestive effects such as diarrhea or constipation, which are generally temporary. The medication does not contain aluminum, offering an alternative to traditional phosphate binders.

Store Velphoro at room temperature away from moisture and heat. Keep the medication in its original packaging until ready to use. Do not crush, chew, or break the tablets, as this may affect how the medication works. Always take Velphoro as directed by a healthcare professional to ensure proper phosphate control.

Velphoro may interact with medications that require acidic conditions for absorption, such as certain antibiotics or thyroid hormones. It is recommended to take these medications at least 1 hour before or 3 hours after Velphoro to avoid reduced effectiveness. Always inform your healthcare provider about all medications and supplements you are taking.